Literature DB >> 19664064

Effects of bacterial treatment at early stages of Atlantic cod (Gadus morhua L.) on larval survival and development.

H L Lauzon1, S Gudmundsdottir, A Steinarsson, M Oddgeirsson, S K Petursdottir, E Reynisson, R Bjornsdottir, B K Gudmundsdottir.   

Abstract

AIMS: To assess the effects of bacterial treatment at the earliest stages of cod rearing on the microbial load, larval development and performance, testing three bacterial strains (Carnobacterium divergens V41, Arthrobacter sp. and Enterococcus sp.) in vivo that were previously shown to have inhibitory potential towards fish pathogens in vitro. METHODS AND
RESULTS: A bacterial mixture was added eight times to the rearing water from the prehatch to the mid-larval stage (a 38-day period). Microbiological analysis of ova, larvae and rearing water was performed regularly. Larval performance and development were evaluated by survival rate, hypersalinity tolerance and physiological measurements. Different larval survival rates were observed within and between treatments, and possibly explained by variations in larval microflora and established probionts. Larvae from one silo, which had been bathed in the bacterial suspension, showed the highest survival rate (42.1%), lowest Vibrio levels, and were significantly heavier (19.3%) and more stress tolerant than control larvae (P < 0.01). This coincided with the intestinal establishment of two of the tested bacteria.
CONCLUSIONS: Arthrobacter and Enterococcus strains added regularly to the rearing water from the postfertilized egg stage can become established in larval gastrointestinal tract. The Enterococcus strain was associated with increased larval growth, performance and microflora control, indicating its probiotic nature. SIGNIFICANCE AND IMPACT OF THE STUDY: Regular application of autochthonous probionts may promote larval welfare, development and stress tolerance at early stages, hence increasing production yield in intensive cod larviculture.

Entities:  

Mesh:

Year:  2009        PMID: 19664064     DOI: 10.1111/j.1365-2672.2009.04454.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  7 in total

Review 1.  Immunological control of fish diseases.

Authors:  Bergljot Magnadottir
Journal:  Mar Biotechnol (NY)       Date:  2010-03-30       Impact factor: 3.619

2.  Synbiotic (Biomin imbo) alters gut bacterial microflora of Russian sturgeon, Acipenser guldenstadti (Brandt & Ratzeburg, 1833) in a time-dependent pattern.

Authors:  Mahdi Vaezi; Hossein Khara; Alireza Shenavar
Journal:  J Parasit Dis       Date:  2015-02-14

3.  Drivers of ecological assembly in the hindgut of Atlantic Cod fed a macroalgal supplemented diet.

Authors:  C Keating; M Bolton-Warberg; J Hinchcliffe; R Davies; S Whelan; A H L Wan; R D Fitzgerald; S J Davies; C J Smith; U Z Ijaz
Journal:  NPJ Biofilms Microbiomes       Date:  2022-05-04       Impact factor: 8.462

4.  Dietary probiotic supplementation (Shewanella putrefaciens Pdp11) modulates gut microbiota and promotes growth and condition in Senegalese sole larviculture.

Authors:  Carmen Lobo; Xabier Moreno-Ventas; Silvana Tapia-Paniagua; Covadonga Rodríguez; Miguel A Moriñigo; Inés García de La Banda
Journal:  Fish Physiol Biochem       Date:  2013-08-11       Impact factor: 2.794

5.  Probiotic supplementation promotes calcification in Danio rerio larvae: a molecular study.

Authors:  Francesca Maradonna; Giorgia Gioacchini; Silvia Falcinelli; Daniela Bertotto; Giuseppe Radaelli; Ike Olivotto; Oliana Carnevali
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

6.  Egg nutritional modulation with amino acids improved performance in zebrafish larvae.

Authors:  Carmen Navarro-Guillén; Gabriella do Vale Pereira; André Lopes; Rita Colen; Sofia Engrola
Journal:  PLoS One       Date:  2021-04-09       Impact factor: 3.240

7.  Succession of the intestinal bacterial community in Pacific bluefin tuna (Thunnus orientalis) larvae.

Authors:  Akito Taniguchi; Ryuichiro Aoki; Isamu Inoue; Mitsuru Eguchi
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.